SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Doximity, Inc. - DOCS
NEW YORK, NY / ACCESSWIRE / June 1, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Doximity, Inc. ("Doximity" or the "Company") (NYSE:DOCS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.
NYSE: DOCS: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Securities Class Action Lawsuit Filed Against Doximity, Inc.
RADNOR, PA / ACCESSWIRE / June 1, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against Doximity, Inc. (NYSE:DOCS) ("Doximity" or the "Company") on behalf of investors who purchased or acquired Doximity common stock between February 9, 2022, and April 1, 2024, inclusive (the "Class Period"). This action, captioned Kissler v.
IMPORTANT DEADLINE UPDATE: The Schall Law Firm Encourages Investors in Doximity, Inc. with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / June 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Doximity, Inc. ("Doximity" or "the Company") (NYSE:DOCS) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 9, 2022 and April 1, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before June 17, 2024.
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in Doximity, Inc. with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Doximity, Inc. ("Doximity" or "the Company") (NYSE:DOCS) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 9, 2022 and April 1, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before June 17, 2024.
IMMINENT DOCS DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Doximity, Inc. Investors to Join the Class Action Lawsuit!
NEW YORK, NY / ACCESSWIRE / May 31, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Doximity, Inc. ("Doximity" or "the Company") (NYSE: DOCS) and certain of its officers. Class Definition: This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Doximity securities between February 9, 2022 and April 1, 2024, inclusive (the "Class Period").
DOXIMITY SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Doximity, Inc. - DOCS
NEW ORLEANS, LA / ACCESSWIRE / May 30, 2024 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until June 17, 2024 to file lead plaintiff applications in a securities class action lawsuit against Doximity, Inc. (NYSE:DOCS), if they purchased or otherwise acquired the Company's shares between February 9, 2022, and April 1, 2024, inclusive (the "Class Period").
NYSE: DOCS: Kessler Topaz Meltzer & Check, LLP Files a Securities Class Action Lawsuit Against Doximity, Inc.
RADNOR, PA / ACCESSWIRE / May 30, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against Doximity, Inc. (NYSE:DOCS) ("Doximity" or the "Company") on behalf of investors who purchased or acquired Doximity common stock between February 9, 2022, and April 1, 2024, inclusive (the "Class Period"). This action, captioned Kissler v.
Dr Martens' sales nosedive, British footwear brand struggles to capture US market
Iconic British footwear brand Dr Martens PLC (LSE:DOCS) posted expectedly poor full-year results this Thursday, with revenues coming in even worse than initially expected. Revenues of £877.1 million represented a year-on-year decrease of 12.3%, undershooting the 11% drop forecasted by the market.
Doximity (DOCS) Upgraded to Buy: Here's What You Should Know
Doximity (DOCS) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Dr Martens' results to clarify on outlook as bad streak persists
Dr Martens PLC (LSE:DOCS) is expected to report a hefty drop in profit when full-year results come out on Thursday, May 30. This is as the bootmaker nurses heavy losses in the US on falling wholesale revenue.
Doximity is the Facebook and LinkedIn of the Medical Community
Doximity Inc. NASDAQ: DOCS is a social networking platform exclusively designed for U.S. healthcare professionals. It's a cross between Meta Platforms Inc. NASDAQ: META owned Facebook and Microsoft Co. NASDAQ: MSFT owned LinkedIn.
Doximity is the Facebook and LinkedIn of the Medical Community
Doximity Inc. NASDAQ: DOCS is a social networking platform exclusively designed for U.S. healthcare professionals. It's a cross between Meta Platforms Inc. NASDAQ: META owned Facebook and Microsoft Co. NASDAQ: MSFT owned LinkedIn.
